Cargando…

Non-invasive Chemokine Detection: Improved Prediction of Antibody-Mediated Rejection in Donor-Specific Antibody-Positive Renal Allograft Recipients

Background: Screening for donor-specific antibodies (DSA) has limited diagnostic value in patients with late antibody-mediated rejection (ABMR). Here, we evaluated whether biomarkers reflecting microcirculation inflammation or tissue injury—as an adjunct to DSA detection—are able to improve non-inva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mühlbacher, Jakob, Doberer, Konstantin, Kozakowski, Nicolas, Regele, Heinz, Camovic, Sümeyra, Haindl, Susanne, Bond, Gregor, Haslacher, Helmuth, Eskandary, Farsad, Reeve, Jeff, Böhmig, Georg A., Wahrmann, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160229/ https://www.ncbi.nlm.nih.gov/pubmed/32328494 http://dx.doi.org/10.3389/fmed.2020.00114

Ejemplares similares

Diagnostic value of donor‐derived cell‐free DNA to predict antibody‐mediated rejection in donor‐specific antibody‐positive renal allograft recipients
por: Mayer, Katharina A., et al.
Publicado: (2021)

The therapeutic challenge of late antibody‐mediated kidney allograft rejection
por: Böhmig, Georg A., et al.
Publicado: (2019)

Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial
por: Eskandary, Farsad, et al.
Publicado: (2014)

Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Kidney Transplant Rejection: Effect on Donor-derived Cell-free DNA and C-X-C Motif Chemokine Ligand 10
por: Mayer, Katharina A., et al.
Publicado: (2022)

Early Estimated Glomerular Filtration Rate Trajectories After Kidney Transplant Biopsy as a Surrogate Endpoint for Graft Survival in Late Antibody-Mediated Rejection
por: Borski, Anita, et al.
Publicado: (2022)

High-activity Classical and Alternative Complement Pathway Genotypes—Association With Donor-specific Antibody-triggered Injury and Renal Allograft Survival
por: Mező, Blanka, et al.
Publicado: (2020)

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
por: Eskandary, Farsad, et al.
Publicado: (2019)

Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated Rejection
por: Mező, Blanka, et al.
Publicado: (2019)

Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial
por: Mayer, Katharina A., et al.
Publicado: (2022)

Longitudinal assessment of HLA and MIC-A antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetes
por: Küssel, Lorenz, et al.
Publicado: (2017)

Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism
por: Mühlbacher, Jakob, et al.
Publicado: (2021)

Renal allograft DARCness in subclinical acute and chronic active ABMR
por: Kläger, Johannes, et al.
Publicado: (2021)

Functional Fc Gamma Receptor Gene Polymorphisms and Long-Term Kidney Allograft Survival
por: Wahrmann, Markus, et al.
Publicado: (2021)

Levels of donor‐derived cell‐free DNA and chemokines in BK polyomavirus‐associated nephropathy
por: Mayer, Katharina A., et al.
Publicado: (2022)

Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients—A prospective observational trial
por: Doberer, Konstantin, et al.
Publicado: (2020)

Effect of the Anti‐C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody–Induced Complement Activation—A Preclinical In Vitro Study
por: Wahrmann, M., et al.
Publicado: (2017)

Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009—Results from a Randomized First-in-Human Phase 1 Trial
por: Mühlbacher, Jakob, et al.
Publicado: (2017)

Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients
por: Strassl, Robert, et al.
Publicado: (2018)

Torque Teno Virus for Risk Stratification of Acute Biopsy-Proven Alloreactivity in Kidney Transplant Recipients
por: Strassl, Robert, et al.
Publicado: (2019)

Torque Teno Virus Load Is Associated With Subclinical Alloreactivity in Kidney Transplant Recipients: A Prospective Observational Trial
por: Doberer, Konstantin, et al.
Publicado: (2021)

Magnetic Resonance Imaging for Evaluation of Interstitial Fibrosis in Kidney Allografts
por: Beck-Tölly, Andrea, et al.
Publicado: (2020)

Non-invasive screening for sub-clinical antibody-mediated rejection as a new tool for indication of kidney allograft biopsy
por: Kozakowski, Nicolas
Publicado: (2019)

Deletion of the Natural Killer Cell Receptor NKG2C Encoding KLR2C Gene and Kidney Transplant Outcome
por: Vietzen, Hannes, et al.
Publicado: (2022)

Early Eosinophilic Antibody-mediated Rejection in a Renal Allograft Recipient
por: Satish, H., et al.
Publicado: (2018)

Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination—A Non-randomized, Controlled Pilot Study
por: Regele, Florina, et al.
Publicado: (2022)

Donor plasma mitochondrial DNA is associated with antibody-mediated rejection in renal allograft recipients
por: Han, Fei, et al.
Publicado: (2021)

Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial
por: Reindl-Schwaighofer, Roman, et al.
Publicado: (2021)

ABO-Incompatibility: Time to Challenge the Paradigm of Equivalence in Live-Donor Kidney Transplantation?
por: Eskandary, Farsad, et al.
Publicado: (2022)

Role of anti-vimentin antibodies in allograft rejection
por: Rose, Marlene L
Publicado: (2013)

Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2016)

Analysis of Sera of Recipients with Allograft Rejection Indicates That Keratin 1 Is the Target of Anti-Endothelial Antibodies
por: Guo, Xuli, et al.
Publicado: (2017)

Recipient myeloperoxidase-producing cells regulate antibody-mediated acute versus chronic kidney allograft rejection
por: Miyairi, Satoshi, et al.
Publicado: (2021)

Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection
por: Hancock, Wayne W., et al.
Publicado: (2000)

Study of CC chemokine receptor 5 in renal allograft rejection
por: Ghosh, R., et al.
Publicado: (2013)

Case Report: Splenic Irradiation for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Allograft Recipients With De Novo Donor-Specific Antibodies
por: Zhu, Lan, et al.
Publicado: (2021)

THE ROLE OF HUMORAL ANTIBODY IN THE REJECTION OF PRIMARY RENAL ALLOGRAFTS IN SHEEP
por: Pedersen, Niels C., et al.
Publicado: (1974)

Acute antibody-mediated renal allograft rejection associated with HLA-Cw17 antibody
por: Suneja, Manish, et al.
Publicado: (2012)

Chemokine Profiles Are Affected in Serum of Patients with Acute Rejection of Kidney Allograft
por: Krupickova, Lenka, et al.
Publicado: (2021)

Antibody-Mediated Rejection of Arterialised Venous Allografts Is Inhibited by Immunosuppression in Rats
por: Splith, Katrin, et al.
Publicado: (2014)

Treatment of Antibody-Mediated Renal Allograft Rejection: Improving Step by Step
por: Lachmann, Nils, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8jhfilun8u1ksip797fn2cfjbr